Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2024 Feb 22;19(2):e0298883. doi: 10.1371/journal.pone.0298883. eCollection 2024.
Many forms of childhood glaucoma have been associated with underlying genetic changes, and variants in many genes have been described. Currently, testing is variable as there are no widely accepted guidelines for testing. This systematic review aimed to summarize the literature describing genetic changes and testing practices in childhood glaucoma. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic review and Meta-Analyses (PRISMA) 2020 guidelines and registered with Prospero (ID CRD42023400467). A comprehensive review of Pubmed, Embase, and Cochrane databases was performed from inception through March 2, 2023 using the search terms: (glaucoma) AND (pediatric OR childhood OR congenital OR child OR infant OR infantile) AND (gene OR genetic OR genotype OR locus OR genomic OR mutation OR variant OR test OR screen OR panel). Information was extracted regarding genetic variants including genotype-phenotype correlation. Risk of bias was assessed using the Newcastle-Ottawa Scale. Of 1,916 records screened, 196 studies met inclusion criteria and 53 genes were discussed. Among study populations, mean age±SD at glaucoma diagnosis was 8.94±9.54 years and 50.4% were male. The most common gene discussed was CYP1B1, evaluated in 109 (55.6%) studies. CYP1B1 variants were associated with region and population-specific prevalence ranging from 5% to 86% among those with primary congenital glaucoma. MYOC variants were discussed in 31 (15.8%) studies with prevalence up to 36% among patients with juvenile open angle glaucoma. FOXC1 variants were discussed in 25 (12.8%) studies, which demonstrated phenotypic severity dependent on degree of gene expression and type of mutation. Overall risk of bias was low; the most common domains of bias were selection and comparability. Numerous genes and genetic changes have been associated with childhood glaucoma. Understanding the most common genes as well as potential genotype-phenotype correlation has the potential to improve diagnostic and prognostic outcomes for children with glaucoma.
许多类型的儿童青光眼都与潜在的遗传变化有关,许多基因的变异也已被描述。目前,由于缺乏广泛接受的检测指南,检测方法存在差异。本系统评价旨在总结描述儿童青光眼遗传变化和检测实践的文献。本系统评价按照《系统评价和荟萃分析的首选报告项目(PRISMA)》2020 年指南进行,并在 Prospero(ID CRD42023400467)上进行了注册。从成立到 2023 年 3 月 2 日,通过使用搜索词“(青光眼)和(儿科或儿童或先天性或儿童或婴儿或婴儿)和(基因或遗传或基因型或基因座或基因组或突变或变体或测试或筛选或面板)”,对 Pubmed、Embase 和 Cochrane 数据库进行了全面的回顾。提取了有关遗传变异的信息,包括基因型-表型相关性。使用纽卡斯尔-渥太华量表评估偏倚风险。在筛选出的 1916 条记录中,有 196 项研究符合纳入标准,其中讨论了 53 个基因。在研究人群中,青光眼诊断时的平均年龄±标准差为 8.94±9.54 岁,男性占 50.4%。讨论最多的基因是 CYP1B1,有 109 项(55.6%)研究评估了该基因。CYP1B1 变异与特定地区和人群的患病率有关,原发性先天性青光眼患者的患病率从 5%到 86%不等。在 31 项(15.8%)研究中讨论了 MYOC 变异,在青少年开角型青光眼患者中,患病率高达 36%。在 25 项(12.8%)研究中讨论了 FOXC1 变异,这些研究表明表型严重程度取决于基因表达程度和突变类型。整体偏倚风险较低;最常见的偏倚领域是选择和可比性。许多基因和遗传变化与儿童青光眼有关。了解最常见的基因以及潜在的基因型-表型相关性,有可能改善儿童青光眼的诊断和预后结果。